ArticleExploration of targeted anti-tumor therapy2023

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy.

Stijn Hentzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.